Drug screening platform using human induced pluripotent stem cell‐derived atrial cardiomyocytes and optical mapping

In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants

(2019) Sanam Shafaattalab et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes

(2019) Sanam Shafaattalab et al.   Stem Cell Reports

Molecular determinants of the differential modulation of Cav1.2 and Cav1.3 by nifedipine and FPL 64176

(2018) Yuchen Wang et al.   MOLECULAR PHARMACOLOGY

Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes

(2018) Mariana Argenziano et al.   Stem Cell Reports

Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

(2018) Chengyi Tu et al.   CIRCULATION RESEARCH

Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells

(2017) Fei Pei et al.   Stem Cell Research

Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue

(2017) Zachary Laksman et al.   Scientific Reports

Axial tubule junctions control rapid calcium signaling in atria

(2016) Sören Brandenburg et al.   JOURNAL OF CLINICAL INVESTIGATION

Atrial fibrillation

(2016) Gregory Y. H. Lip et al.   Nature Reviews Disease Primers

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Insights Into Molecular, Cellular, and Functional Phenotypes

(2015) I. Karakikes et al.   CIRCULATION RESEARCH

Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology

(2015) H. D. Devalla et al.   EMBO Molecular Medicine

Chemically defined generation of human cardiomyocytes

(2014) Paul W Burridge et al.   NATURE METHODS

Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions

(2012) Xiaojun Lian et al.   Nature Protocols

Effects on Atrial Fibrillation in Aged Hypertensive Rats by Ca 2+ -Activated K + Channel Inhibition

(2011) Jonas G. Diness et al.   HYPERTENSION

Vernakalant: A novel agent for the termination of atrial fibrillation

(2010) M. Finnin   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals

(2010) Qiangzhe Zhang et al.   CELL RESEARCH

Inhibition of Small-Conductance Ca 2+ -Activated K + Channels Terminates and Protects Against Atrial Fibrillation

(2010) Jonas Goldin Diness et al.   Circulation-Arrhythmia and Electrophysiology

Molecular determinants of cardiac transient outward potassium current (Ito) expression and regulation

(2009) Noriko Niwa et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

(2008) Denis Roy et al.   CIRCULATION

Novel Transient Outward and Ultra-rapid Delayed Rectifier Current Antagonist, AVE0118, Protects Against Ventricular Fibrillation Induced by Myocardial Ischemia

(2008) George E Billman et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Direct multiplexed measurement of gene expression with color-coded probe pairs

(2008) Gary K Geiss et al.   NATURE BIOTECHNOLOGY